Contact us for product
availability and pricing.

A study reporting a new method to detect early-stage liver cancer was recently published in the journal Science Advances. This method uses a protein-based MRI contrast agent targeting the CXCR4 receptor associated with certain metastatic cancer cells, and a new precision MRI (pMRI) imaging methodology, to enable earlier detection of cancer. Early detection is expected to result in better treatment options and improved patient outcomes.

This new technology was developed in the lab of Dr. Jenny Yang at Georgia State University, and collaborator’s from Emory University, and was recently featured in a GSU media release.